UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Breast cancer, side population cells and ABCG2 expression

Cancer letters, 2012-10, Vol.323 (1), p.97-105

2012

Volltextzugriff (PDF)

A novel AKT3 mutation in melanoma tumours and cell lines

British journal of cancer, 2008-10, Vol.99 (8), p.1265-1268

2008

Volltextzugriff (PDF)

Correlation of NRAS mutations with clinical response to high-dose IL-2 in patients with advanced melanoma

Journal of immunotherapy (1997), 2012-01, Vol.35 (1), p.66-72

2012

Volltextzugriff (PDF)

A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast Cancer

Cancer cell, 2007-10, Vol.12 (4), p.395-402

2007

Volltextzugriff (PDF)

531 Evaluation of PTEN and PIK3Ca Status in Breast Cancer for Patient Selection – Cross-validation Between Institutions

European journal of cancer (1990), 2012-07, Vol.48, p.S126-S126

2012

Volltextzugriff (PDF)

Expression Library Immunization: a Road Map for Discovery of Vaccines against Infectious Diseases

Infection and immunity, 2005-11, Vol.73 (11), p.7089-7098

2005

Volltextzugriff (PDF)

Direct Association between the Yeast Rad51 and Rad54 Recombination Proteins

The Journal of biological chemistry, 1996-12, Vol.271 (52), p.33181-33186

1996

Volltextzugriff (PDF)

Screening the whole genome of a pathogen in vivo for individual protective antigens

Vaccine, 2005-04, Vol.23 (23), p.3016-3025

2005

Volltextzugriff (PDF)

The Phage T4 uvsY Recombination Protein Stabilizes Presynaptic Filaments

The Journal of biological chemistry, 1989-10, Vol.264 (28), p.16451-16457

1989

Volltextzugriff (PDF)

Applications of, and future challenges for, genetic vaccines

Developments in biologicals, 2000, Vol.104, p.3

2000

Volltextzugriff (PDF)

Evaluation of PTEN and PIK3CA Status in Breast Cancer for Patient Selection

Annals of oncology, 2012-09, Vol.23, p.ix84

2012

Volltextzugriff (PDF)

P5-01-05: Activating Mutations in PIK3CA or AKT1 in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657)

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P5-P5-01-05

2011

Volltextzugriff (PDF)

The phage T4 uvs Y recombination protein stabilizes presynaptic filaments

The Journal of biological chemistry, 1989-10, Vol.264 (28), p.16451-16457

1989

Volltextzugriff (PDF)

Could side population cells be an indicator of progression to hormone nonresponsive breast cancer

Breast cancer research : BCR, 2010-05, Vol.12 (Suppl 1), p.P30-P30, Article P30

2010

Volltextzugriff (PDF)

Use of gene expression patterns post neoadjuvant chemotherapy to identify a role for the MAPK phosphatase DUSP4 in therapeutic resistance and a stem-like phenotype in basal-like breast cancer (BLBC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.10509-10509

2011

Volltextzugriff (PDF)

Use of mutation profiling of breast cancer using sequenom technology to detect distinct mutation patterns in triple-negative compared to receptor-positive cancers

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.1039-1039

2010

Volltextzugriff (PDF)

Quantitative assessment of AKT activation in melanoma

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.9022-9022

2009

Volltextzugriff (PDF)

Selective activity of dasatinib for the most common KIT mutation in melanoma (L576P)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.9019-9019

2009

Volltextzugriff (PDF)

Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

Cancer research (Chicago, Ill.), 2009-05, Vol.69 (10), p.4116-4124

2009

Volltextzugriff (PDF)

The RAC1 P29S Hotspot Mutation in Melanoma Confers Resistance to Pharmacological Inhibition of RAF

Cancer research (Chicago, Ill.), 2014-09, Vol.74 (17), p.4845-4852

2014

Volltextzugriff (PDF)

An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer

Cancer research (Chicago, Ill.), 2008-08, Vol.68 (15), p.6084-6091

2008

Volltextzugriff (PDF)

Detection algorithm for the validation of human cell lines

International journal of cancer, 2012-09, Vol.131 (6), p.E1024-E1030

2012

Volltextzugriff (PDF)

Exome sequencing identifies GRIN2A as frequently mutated in melanoma

Nature genetics, 2011-05, Vol.43 (5), p.442-446

2011

Volltextzugriff (PDF)

Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer

Clinical cancer research, 2011-03, Vol.17 (5), p.1082-1089

2011

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Humans
(14)
Biological And Medical Sciences
(11)
Oncology
(11)
Female
(9)
Mutation
(8)
Medical Sciences
(7)
Tumors
(7)
Cell Line, Tumor
(6)
Fundamental And Applied Biological Sciences. Psychology
(6)
Breast Neoplasms - Genetics
(5)
Dermatology
(5)
Melanoma
(5)
Proteins
(5)
Tumors Of The Skin And Soft Tissue. Premalignant Lesions
(5)
Aged
(4)
Antineoplastic Agents
(4)
Breast Neoplasms - Pathology
(4)
Class I Phosphatidylinositol 3-Kinases
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Breast cancer, side population cells and ABCG2 expression

A novel AKT3 mutation in melanoma tumours and cell lines

Correlation of NRAS mutations with clinical response to high-dose IL-2 in patients with advanced melanoma

A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast Cancer

531 Evaluation of PTEN and PIK3Ca Status in Breast Cancer for Patient Selection – Cross-validation Between Institutions

AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer

Expression Library Immunization: a Road Map for Discovery of Vaccines against Infectious Diseases

Direct Association between the Yeast Rad51 and Rad54 Recombination Proteins

Screening the whole genome of a pathogen in vivo for individual protective antigens

The Phage T4 uvsY Recombination Protein Stabilizes Presynaptic Filaments

Applications of, and future challenges for, genetic vaccines

Evaluation of PTEN and PIK3CA Status in Breast Cancer for Patient Selection

P5-01-05: Activating Mutations in PIK3CA or AKT1 in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657)

The phage T4 uvs Y recombination protein stabilizes presynaptic filaments

Could side population cells be an indicator of progression to hormone nonresponsive breast cancer

Use of gene expression patterns post neoadjuvant chemotherapy to identify a role for the MAPK phosphatase DUSP4 in therapeutic resistance and a stem-like phenotype in basal-like breast cancer (BLBC)

Use of mutation profiling of breast cancer using sequenom technology to detect distinct mutation patterns in triple-negative compared to receptor-positive cancers

Quantitative assessment of AKT activation in melanoma

Selective activity of dasatinib for the most common KIT mutation in melanoma (L576P)

Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

The RAC1 P29S Hotspot Mutation in Melanoma Confers Resistance to Pharmacological Inhibition of RAF

An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer

Detection algorithm for the validation of human cell lines

Exome sequencing identifies GRIN2A as frequently mutated in melanoma

Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer

Suchergebnisse filtern